Live Breaking News & Updates on Eccles Institute

Stay updated with breaking news from Eccles institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer


Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
News provided by
Share this article
Share this article
SHANGHAI, April 14, 2021 /PRNewswire/ Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies.
We are pleased to welcome Dr. Yang to Everest s leadership team. Jennifer s deep expertise in drug discovery and translational medicine combined with her extensive experience in global development will be invaluable to the Company.  She will establish a strong discovery organization that contributes to the strategic expansion of our clinical development pipeline, ....

United States , Jennifer Yang , Kerry Blanchard , Eli Lilly , University Of Utah , Eccles Institute Of Human Genetics , Pfizer Inc Oncology Research Unit , Janssen China Research Development Center , Fudan University , Southern Illinois University , Johnson Lung Cancer Initiative , Discovery Center , Greater China , Everest Medicines , Everest Medicine , Lung Cancer Initiative , Development Center , Eccles Institute , Human Genetics , ஒன்றுபட்டது மாநிலங்களில் , ஜெனிபர் யாங் , கெர்ரி பிளான்சார்ட் , எலி லில்லி , பல்கலைக்கழகம் ஆஃப் உட்டா , தெற்கு இல்லினாய்ஸ் பல்கலைக்கழகம் , ஜான்சன் நுரையீரல் புற்றுநோய் முயற்சி ,